Navigation Links
New UV-C-Reflective Wall Coating Dramatically Reduces Disinfection Times for TRU-D Device

CHAPEL HILL, N.C., May 10, 2013 /PRNewswire/ -- A recent study published in Infection Control and Hospital Epidemiology ( William A. Rutala , Ph.D., MPH, et al., 2013) confirms the ability of a new UV-C-reflective wall coating to dramatically reduce the time necessary to decontaminate a room using the UV-C-emitting device TRU-D SmartUVC™.

TRU-D, the signature product of Memphis-based Lumalier, is the only portable UV disinfection system on the market that precisely measures reflected UV-C emissions with Sensor360™ to automatically calculate the pathogen-lethal UV dose required for proper and consistent disinfection of health care environments. Thanks to the device's patented technology and intuitive nature, TRU-D "sees" the reflective properties in the wall coating and automatically adjusts the cycle time to the appropriate dose of UV-C emission necessary to disinfect the room of harmful pathogens.

The study, which utilized a TRU-D device in a patient hospital room at University of North Carolina Clinical Translational Research Center in Chapel Hill, tested the difference in cycle time necessary to achieve microbial termination on 10 inoculated templates placed at various locations throughout the room before and after the room was coated with the new UVC360™ Reflective Wall Coating from Lumacept. Rutala and his team concluded the following time reductions for decontamination: methicillin-resistant Staphylococcus aureus, from 25 minutes 13 seconds to five minutes three seconds, and Clostridium difficile spores, from 43 minutes 42 seconds to nine minutes 24 seconds.

"Because of TRU-D's Sensor360 technology, it is the only UV disinfection device that is able to react to the improved reflectivity of the wall coating, allowing for the precise measurement of necessary UV dose to be adjusted and therefore reduced" said Chuck Dunn , president of Lumalier, maker of TRU-D. "This is a new and highly valuable component for hospitals using TRU-D, as it allows a faster turnaround of patient areas without loss of confidence in complete terminal disinfection."

It has been previously reported that standard approaches to environmental cleaning have proven inadequate with studies showing that 50 percent or more of hospital surfaces go untouched during terminal room disinfection. It is also well-documented that these pathogens, and others such as vancomycin-resistant Enterococcus and carbapenem-resistant Enterobacteriaceae, can persist on environmental surfaces for days, weeks and even months. This can lead to the transmission of these hardy pathogens from one patient to another via the contaminated hands of health care personnel or environmental surfaces in patient areas. Previously published data has supported the use of TRU-D as a complement to a hospital's comprehensive cleaning and disinfection program for effective environmental disinfection in order to reduce these health care-associated infections.

According to the study, the wall coating is similar in appearance to a common interior latex paint and is applied as such (by brush, roller or spray), but it is formulated with inorganic oxides, polymer binders and functional additives with chemical structures that are minimally absorbent of UV-C, and therefore produce a much higher UV reflectivity (65 percent) versus standard paint, which has a low 3 to 7 percent UV reflectivity.

UVC360™ Reflective Wall Coating from Lumacept will be featured in booth 1923 at the 40th annual APIC Conference in Fort Lauderdale.  For information about TRU-D SmartUVC, UVC360 Reflective Wall Coating from Lumacept, and all third-party studies published on the device, visit

For more information, contact:
Kerri Guyton
Obsidian Public Relations
Phone: 662-422-8012

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Lumalier
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
2. The Treatment Landscape for Thyroid Carcinoma Will Change Dramatically Through 2021
3. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
4. Ochsner Health System Dramatically Improves Efficiency Using Hyland Softwares OnBase Solution
5. CVS Caremark Industry-Leading Generic Dispensing Rate Reduces Client Traditional Drug Spend by 3.6 Percent for 2012
6. Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
7. Pre-Sutured Tendon From LifeNet Health Increases Surgeon Efficiency, Reduces Operation Room Time
8. Hands-On Treatment Improves Chronic Low Back Pain, Reduces Medication Use
9. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
10. Improved Device Programming Reduces Inappropriate Therapy and Risk of Death for Implantable Defibrillator Patients
11. Southern Home Medical Once Again Reduces The Companys Issued And Outstanding Preferred Shares
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):